An Evaluation of Two PTSD Assessments in an Active Duty and Military Veteran Sample
U.S. Army Medical Research and Development Command · NCT04180930
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18+ · All sexes
- Healthy volunteers
- Accepted
- Study type
- Observational
- Target enrollment
- 950
- US sites recruiting
- 3
- Study start
- April 15, 2019
- Record last updated
- January 23, 2025
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
Given the high prevalence of post-traumatic stress disorder (PTSD) in veterans and active duty military, the focus of this research study is to test the reliability of two new PTSD assessments, the Clinician Administered PTSD Scale for DSM-5 (CAPS-5) and the PTSD Symptom Scale Interview for DSM-5 (PSSI-5) and compare the results between the two new assessments and the previous "gold standard", the Clinician Administered PTSD Scale for DSM-IV (CAPS-IV). Biomarkers believed to be related to PTSD (e.g., biofluid biomarkers, cognitive and physiological markers, and neural activity as measured by EEG) will be collected to inform targeted interventions in specific groups of patients and other large-scale biomarker discovery efforts in the field. Participants will be 950 male and female active duty military and veterans ages 18 or older who have been exposed to at least one traumatic event.
Being studied: CAPS-5; PSSI-5; CAPS-IV
Conditions: Stress Disorders, Post-Traumatic
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Male or female active duty personnel or military veterans, 18 years of age or older
- Competent to give informed consent
- Have experienced any Criterion A qualifying traumatic event as defined by the Life Events Checklist for DSM-5 (LEC-5)
- Score a 3 or above on the Primary Care-Post Traumatic Stress Disorder Screen (PC-PTSD-5)
Exclusion Criteria
- Current suicidal or homicidal ideation with a plan, and substance use disorder requiring detoxification currently or in the past month as assessed using the SCID and Suicidal Ideation/Homicidal Ideation screening tool (SI/HI screen)
- Assessment using CAPS or PSSI in the previous 1 year
- Currently receiving psychotherapy or counseling for PTSD
- Moderate to sever cognitive impairment as measured by the Montreal Cognitive Assessment (MoCA)
- Meet criteria for unmedicated Bipolar I, Bipolar II, Schizophrenia, or other psychotic disorders in the last month
Recruiting US locations
Tripler Army Medical Center
Honolulu, HI 96859
Site contact: Catherine Uyehara, PhD · 808-433-7163 · catherine.yamauchi2.civ@health.mil
Cincinnati VA Medical Center - Trauma Recovery Center
Fort Thomas, KY 41075
Site contact: Savannah Noppert, MS · 513-861-3100 · savnnah.noppert@va.gov
Walter Reed National Military Medical Center
Bethesda, MD 20814
Site contact: Nathalie Jimenez · 202-377-9687 · nathalie.t.jimenez.ctr@health.mil
Study contacts (from the official record)
- Savannah Noppert · 513-861-3100 · savannah.noppert@va.gov
- Derrell Anderson, MS · 513-861-3100 · derrell.anderson@va.gov
Similar studies in Hawaii
All mental health studies in Hawaii →- RecruitingHealthy volunteers
Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure
Ecotera Health LLC
- Location
- Honolulu, HI + 50 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
ACADIA Pharmaceuticals Inc.
- Location
- Honolulu, HI + 27 other US sites
- Eligibility basics
- Ages 55–84
- RecruitingPhase 3
Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis
ACADIA Pharmaceuticals Inc.
- Location
- Honolulu, HI + 17 other US sites
- Eligibility basics
- Ages 55–84